{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:28:14Z","timestamp":1775176094247,"version":"3.50.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Diuretics are first-line drugs in symptomatic heart failure treatment. Diabetes <jats:italic toggle=\"yes\">mellitus<\/jats:italic> has been suggested as a determinant of diuretic resistance. Studies comparing the dose and efficacy of diuretics in patients with and without diabetes are lacking. We aimed to study if furosemide dose differed according to diabetes status.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We studied two cohorts of heart failure patients: a cohort of acute heart failure patients consecutively hospitalized with the primary diagnosis of heart failure and another of stable and optimized patients followed in a heart failure clinic. Data on comorbidities and medication were abstracted from patients\u2019 files. Use and doses of furosemide were compared between diabetic and nondiabetic patients. Regression analysis was used to determine the association of variables with diuretic dose. The independent association of diabetes with furosemide dose was assessed using multivariate models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We studied 865 heart failure patients: 601 acute heart failure patients and 264 chronic stable heart failure patients. Acute heart failure patients with diabetes were more likely to need intravenous diuretic therapy and they were also more often discharged under higher doses of furosemide. They needed extra 6-mg furosemide at discharge in comparison with their nondiabetics counterparts and had an independent 26% higher odds of being discharged with at least 80-mg furosemide. Chronic patients were also more frequently prescribed with furosemide and on higher doses, although, diabetes was not independently associated with the use of higher furosemide doses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Diabetic patients are more intensively treated with the loop diuretic furosemide. In acute heart failure, diabetes is an independent predictor of furosemide dose.<\/jats:p>\n          <\/jats:sec>","DOI":"10.2459\/jcm.0000000000000896","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T10:20:35Z","timestamp":1573554035000},"page":"21-26","source":"Crossref","is-referenced-by-count":12,"title":["Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients"],"prefix":"10.2459","volume":"21","author":[{"given":"Filipe M.","family":"Cunha","sequence":"first","affiliation":[{"name":"Endocrinology Department, Centro Hospitalar do T\u00e2mega e Sousa, Penafiel"}]},{"given":"Joana","family":"Pereira","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o"}]},{"given":"Pedro","family":"Marques","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o"}]},{"given":"Ana","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o"}]},{"given":"Paulo","family":"Bettencourt","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hospital CUF Porto"},{"name":"Porto Cardiovascular I&D Unit (UnIC), Faculdade de Medicina da Universidade do Porto"}]},{"given":"Patr\u00edcia","family":"Louren\u00e7o","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o"},{"name":"Heart Failure Clinic of the Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"}]}],"member":"276","reference":[{"key":"R1-20230817","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.116.024593","article-title":"Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction: a report from the I-preserve trial (Irbesartan in Heart Failure with Preserved Ejection Fraction)","volume":"135","author":"Kristensen","year":"2017","journal-title":"Circulation"},{"key":"R2-20230817","doi-asserted-by":"crossref","first-page":"350289","DOI":"10.1155\/2013\/350289","article-title":"Is the blood pressure paradox observed in all heart failure patients?","volume":"2013","author":"Cunha","year":"2013","journal-title":"Biomed Res Int"},{"key":"R3-20230817","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/eurjhf\/hfs153","article-title":"Association between diabetes mellitus and postdischarge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial","volume":"15","author":"Sarma","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"R4-20230817","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"R5-20230817","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2337\/diacare.28.3.612","article-title":"The association between glucose abnormalities and heart failure in the population-based Reykjavik study","volume":"28","author":"Thrainsdottir","year":"2005","journal-title":"Diabetes Care"},{"key":"R6-20230817","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"key":"R7-20230817","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R8-20230817","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2337\/dc16-2016","article-title":"Association between diabetes and 1-year adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure: results from the ESC-HFA Heart Failure Long-Term Registry","volume":"40","author":"Dauriz","year":"2017","journal-title":"Diabetes Care"},{"key":"R9-20230817","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1479164112471064","article-title":"Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and nonischaemic aetiology","volume":"10","author":"Cubbon","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"R10-20230817","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ejhf.1170","article-title":"Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Seferovic","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"R11-20230817","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10741-018-9685-0","article-title":"The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions","volume":"23","author":"Ofstad","year":"2018","journal-title":"Heart Fail Rev"},{"key":"R12-20230817","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"R13-20230817","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","article-title":"Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial","volume":"373","author":"Home","year":"2009","journal-title":"Lancet"},{"key":"R14-20230817","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"R15-20230817","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"R16-20230817","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N Engl J Med"},{"key":"R17-20230817","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mhj.2002.123144","article-title":"Diuretic resistance predicts mortality in patients with advanced heart failure","volume":"144","author":"Neuberg","year":"2002","journal-title":"Am Heart J"},{"key":"R18-20230817","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","article-title":"Diuretic response in acute heart failure: clinical characteristics and prognostic significance","volume":"35","author":"Valente","year":"2014","journal-title":"Eur Heart J"},{"key":"R19-20230817","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ejhf.170","article-title":"Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome \u2013 an analysis from RELAX-AHF","volume":"16","author":"Voors","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"R20-20230817","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","article-title":"Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure","volume":"7","author":"Testani","year":"2014","journal-title":"Circ Heart Fail"},{"key":"R21-20230817","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ahj.2015.05.003","article-title":"Diuretic response in acute heart failure-an analysis from ASCEND-HF","volume":"170","author":"ter Maaten","year":"2015","journal-title":"Am Heart J"},{"key":"R22-20230817","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00392-015-0896-2","article-title":"A combined clinical and biomarker approach to predict diuretic response in acute heart failure","volume":"105","author":"ter Maaten","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"R23-20230817","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(14)61402-1","article-title":"Heart failure in diabetes: effects of antihyperglycaemic drug therapy","volume":"385","author":"Gilbert","year":"2015","journal-title":"Lancet"},{"key":"R24-20230817","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/ki.1993.224","article-title":"Role of hyperglycemia and insulin resistance in determining sodium retention in noninsulin-dependent diabetes","volume":"44","author":"Nosadini","year":"1993","journal-title":"Kidney Int"},{"key":"R25-20230817","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/BF00274259","article-title":"Effects of insulin on kidney function and sodium excretion in healthy subjects","volume":"32","author":"Skott","year":"1989","journal-title":"Diabetologia"},{"key":"R26-20230817","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1136\/heartjnl-2014-305747","article-title":"Low prealbumin is strongly associated with adverse outcome in heart failure","volume":"100","author":"Lourenco","year":"2014","journal-title":"Heart"},{"key":"R27-20230817","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijcard.2017.03.042","article-title":"Dipeptidyl peptidase-IV in chronic heart failure with reduced ejection fraction","volume":"241","author":"Lourenco","year":"2017","journal-title":"Int J Cardiol"},{"key":"R28-20230817","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cardfail.2015.12.007","article-title":"Response to exercise training and outcomes in patients with heart failure and diabetes mellitus: insights from the HF-ACTION Trial","volume":"22","author":"Banks","year":"2016","journal-title":"J Card Fail"},{"key":"R29-20230817","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.diabres.2014.03.015","article-title":"Association between type-2 diabetes mellitus and postdischarge outcomes in heart failure patients: findings from the RICA registry","volume":"104","author":"Carrasco-Sanchez","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"R30-20230817","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002560","article-title":"Risk related to pre-diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial","volume":"9","author":"Kristensen","year":"2016","journal-title":"Circ Heart Fail"},{"key":"R31-20230817","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"R32-20230817","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ejhf.679","article-title":"In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry","volume":"19","author":"Targher","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"R33-20230817","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cardfail.2011.08.010","article-title":"Dynamics in insulin resistance and plasma levels of adipokines in patients with acute decompensated and chronic stable heart failure","volume":"17","author":"Schulze","year":"2011","journal-title":"J Card Fail"},{"key":"R34-20230817","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1172\/JCI107996","article-title":"The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man","volume":"55","author":"DeFronzo","year":"1975","journal-title":"J Clin Invest"},{"key":"R35-20230817","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0895-7061(96)00098-2","article-title":"Effect of insulin on renal sodium and uric acid handling in essential hypertension","volume":"9","author":"Muscelli","year":"1996","journal-title":"Am J Hypertens"},{"key":"R36-20230817","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1042\/cs0850327","article-title":"Relationship between insulin release, antinatriuresis and hypokalaemia after glucose ingestion in normal and hypertensive man","volume":"85","author":"Natali","year":"1993","journal-title":"Clin Sci"},{"key":"R37-20230817","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/eurjhf\/hfq160","article-title":"Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study","volume":"12","author":"Andersson","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"R38-20230817","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.100.9.999","article-title":"Mechanisms and models in heart failure: a combinatorial approach","volume":"100","author":"Mann","year":"1999","journal-title":"Circulation"},{"key":"R39-20230817","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00125-014-3259-z","article-title":"Association of heart failure severity with risk of diabetes: a Danish nationwide cohort study","volume":"57","author":"Demant","year":"2014","journal-title":"Diabetologia"},{"key":"R40-20230817","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.CIR.0000054611.89228.92","article-title":"Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD)","volume":"107","author":"Vermes","year":"2003","journal-title":"Circulation"}],"container-title":["Journal of Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.2459\/JCM.0000000000000896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T02:23:13Z","timestamp":1692325393000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.2459\/JCM.0000000000000896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2459\/jcm.0000000000000896","relation":{},"ISSN":["1558-2027","1558-2035"],"issn-type":[{"value":"1558-2027","type":"print"},{"value":"1558-2035","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}